Natco Pharma Ltd. (NATCOPHARM) - Financials, balance sheet (annual)

847 INR

5.75

0.67%

Last update Sep 8, 3:29 PM IST

Main market

Day range

847

844.79999

860.95001

Previous close

852.75

Open

857.79999

Access this stock data via API

Natco Pharma Ltd.

847.00

5.75

0.67%

Financials

Balance sheet

Fiscal date	2025	2024	2023	2022
Total assets	86.3B	69.1B	56.6B	51.1B
Current assets	52.7B	40.2B	30.0B	24.9B
Cash	—	641M	1.3B	1.1B
Cash equivalents	—	63M	0	—
Cash and cash equivalents	1.2B	704M	1.3B	1.1B
Other short term investments	28.0B	17.1B	9.9B	6.5B
Accounts receivable	12.5B	11.9B	8.6B	6.2B
Other receivables	94M	796M	453M	649M
Inventory	7.7B	7.0B	7.4B	7.6B
Prepaid assets	—	2.7B	2.3B	2.7B
Restricted cash	—	31M	47M	37M
Assets held for sale	—	—	—	—
Hedging assets	—	—	0	10M
Other current assets	3.3B	2.8B	2.3B	3.0B
Non current assets	33.6B	28.8B	26.6B	26.2B
Properties	24.3B	503M	450M	556M
Land and improvements	—	3.7B	2.9B	2.6B
Machinery furniture equipment	—	18.3B	17.6B	16.8B
Construction in progress	2.3B	1.4B	643M	1.3B
Leases	—	—	—	—
Accumulated depreciation	—	-10.6B	-9.1B	-7.9B
Goodwill	3.2B	2.5B	2.4B	1.8B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	2.1B	1.4B	1.3B	822M
Investments and advances	—	—	—	—
Other non current assets	490M	694M	271M	469M
Total liabilities	10.2B	10.5B	7.8B	8.5B
Current liabilities	9.4B	9.7B	6.8B	7.1B
Accounts payable	2.7B	2.4B	2.6B	1.6B
Accrued expenses	—	—	—	—
Short term debt	2.7B	3.8B	1.8B	4.2B
Deferred revenue	—	—	—	—
Tax payable	790M	323M	101M	9M
Pensions	—	1.0B	169M	170M
Other current liabilities	1.2B	488M	546M	369M
Non current liabilities	750M	804M	1.0B	1.4B
Long term provisions	656M	709M	853M	957M
Long term debt	46M	53M	11M	80M
Provision for risks and charges	—	—	—	—
Deferred liabilities	2M	2M	124M	301M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	-42.6B	—
Shareholders equity
Common stock	358M	358M	365M	365M
Retained earnings	—	44.7B	32.9B	26.7B
Other shareholders equity	—	—	—	—
Total shareholders equity	76.1B	58.5B	48.7B	42.6B
Additional paid in capital	—	12.0B	14.1B	14.1B
Treasury stock	—	—	—	—
Minority interest	53M	0	0	0